title: [Retrograde ejaculation from the urologic viewpoint and the current status of therapeutic possibilities].
abstract: The successful treatment of ejaculatory disturbances is an unresolved problem even today, especially in the patient group of young men after retroperitoneal lymph node dissection because of testicular cancer. A promising therapeutic measure is the treatment with alpha-sympathicomimetics as Pryleugan and Gutron. Pryleugan is recommended as a first- line treatment, whereas Gutron is indicated after failure of this initial therapy. After unsuccessful medical treatment a procedure of sperm production, conservation and insemination is presented. A close cooperation between urologists and gynecologists is necessary for higher therapeutic success rates in ejaculatory disturbances.
authors: Klinik für Urologie des Bereiches Medizin der Wilhelm-Pieck-Universität Rostock.
authors: B
authors: B
authors: Drawz
authors: G
authors: G
authors: Drawz
authors: W D
authors: WD
authors: Berndt
authors: E
authors: E
authors: Heydel
authors: T
authors: T
authors: Erdmann
mesh_terms: D004542:Ejaculation; D005307:Fertilization in Vitro; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage; D007248:Infertility, Male / Q000628:therapy*; D007317:Insemination, Artificial, Homologous; D008297:Male; D008879:Midodrine / Q000008:administration & dosage; D013076:Sperm Count / Q000187:drug effects
chemical_list: D008879:Midodrine; D007099:Imipramine
vernacular_title: Die retrograde Ejakulation aus urologischer Sicht und der gegenwärtige Stand der therapeutischen Möglichkeiten.